Interferons Market Set for Remarkable Growth: Multiple Sclerosis and COVID-19 Impact Key Drivers
A recent preliminary research report from Fairfield Market Research has shed light on the promising growth prospects of the global interferons market over the next few years. The market is set to experience significant expansion, driven by various factors, including the ascending prevalence of multiple sclerosis (MS), the COVID-19 pandemic’s impact, strategic collaborations among industry players, growing healthcare awareness, and continuous research and development efforts.
Ascending Prevalence of Multiple Sclerosis Boosts Demand
Interferons, known for their immunological control, antiviral actions, and cell growth inhibition properties, are witnessing increased demand. Their ability to combat viral infections and protect cells has garnered attention, particularly in the treatment of chronic diseases such as hepatitis B, hepatitis C, cancers, and multiple sclerosis. With combination therapies and innovative drug delivery systems, interferons are showing promising results. The global prevalence of MS is estimated to reach 2.8 million by 2020, contributing to the expanding market.
COVID-19 Impact Accelerates Market Growth
The ongoing COVID-19 pandemic has further accelerated the interferons market. Researchers are exploring existing drugs and developing new ones to combat the virus. For instance, inhalation formulations like SNG001 are being tested in clinical trials, offering potential treatment options for COVID-19. This ongoing research and development are expected to support market expansion.
Strategic Collaboration Drives Growth
Increasing approvals of interferon-beta formulations by regulatory agencies and strategic collaborations among major players are enhancing market visibility and product distribution. For example, licensing agreements and research partnerships, like the one between Bayer and Curadev, are contributing to market growth by developing novel therapeutics for auto-inflammatory diseases.
Rising Healthcare Awareness Fuels Market
Growing health consciousness among individuals is driving the market as pharmaceutical companies invest in the development of drugs for various conditions, including squamous cell carcinoma. The rising prevalence of cancer, hepatitis, and MS is prompting pharmaceutical companies to produce interferon biosimilar medicines, intensifying market competition.
Challenges in Skilled Workforce and High Costs
Despite the positive outlook, the interferons market faces challenges such as a shortage of qualified professionals and high treatment costs. Interferons require substantial investments in research and development and have higher production costs compared to small molecule drugs.
Interferon Beta Dominates Market
Segmented by product, interferon beta holds the largest market share, primarily due to its use in treating multiple sclerosis. The market for interferon-beta is expected to grow as the incidence of multiple sclerosis rises.
Hospital Pharmacies Lead in End-User Segment
In the end-user segment, hospital pharmacies dominate, given the need for qualified physicians in administering interferon treatments. Hospital pharmacies also play a crucial role in liver cancer treatment using interferon therapy.
North America Takes the Lead, Asia Pacific Shows Promise
North America is expected to lead the global interferons market, driven by advanced medical infrastructure and rising disease incidences. In contrast, the Asia Pacific region shows promise with increased government awareness campaigns and the development of generic medicines.
Key players in the interferons market include Roche, Merck & Co., Bristol-Myers Squibb, Biogen Inc., Bayer AG, Zydus Cadila, Novartis AG, Pfizer Inc., Biosidus, Synairgen, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, Schering-Plough Corporation, 3Sbio, and F. Hoffmann La-Roche Ltd.
The global interferons market is on the cusp of substantial growth, with a myriad of factors poised to shape its trajectory in the coming years. As research and development efforts continue and strategic collaborations evolve, the market is set to offer new opportunities and innovative solutions for patients worldwide.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/interferons-market
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad